2022
Epidemiology and outcomes of surgical site infections among pediatric liver transplant recipients
Banach DB, Lopez‐Verdugo F, Sanchez‐Garcia J, Tran A, Gomez‐Llerena A, Munoz‐Abraham A, Bertacco A, Valentino PL, Yoo P, Dembry L, Mulligan DC, Ekong UD, Emre SH, Rodriguez‐Davalos M. Epidemiology and outcomes of surgical site infections among pediatric liver transplant recipients. Transplant Infectious Disease 2022, 24: e13941. PMID: 35989545, DOI: 10.1111/tid.13941.Peer-Reviewed Original ResearchConceptsSurgical site infectionLiver transplant recipientsLiver transplantationBiliary complicationsGraft recipientsTransplant recipientsSite infectionRisk factorsOutcomes of SSIPediatric liver transplant recipientsLong-term graftPediatric liver transplantationRetrospective descriptive analysisPrimary endpointHospital daysPatient agePediatric populationPatient survivalSignificant causeComplicationsPatientsRecipientsOutcomesInfectionIncidence
2012
Localized Mucosal Response to Intranasal Live Attenuated Influenza Vaccine in Adults
Barría MI, Garrido JL, Stein C, Scher E, Ge Y, Engel SM, Kraus TA, Banach D, Moran TM. Localized Mucosal Response to Intranasal Live Attenuated Influenza Vaccine in Adults. The Journal Of Infectious Diseases 2012, 207: 115-124. PMID: 23087433, PMCID: PMC3571238, DOI: 10.1093/infdis/jis641.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, IntranasalAdolescentAdultAnimalsAntibodies, ViralCohort StudiesCytokinesDogsFemaleHemagglutinin Glycoproteins, Influenza VirusHumansImmunity, MucosalImmunoglobulin AInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeInfluenza B virusInfluenza VaccinesInfluenza, HumanMadin Darby Canine Kidney CellsMaleMiddle AgedNasal Lavage FluidVaccinationVaccines, AttenuatedVaccines, InactivatedYoung AdultConceptsNasal washesInfluenza vaccineMajor public health burdenSerum G-CSF levelsLive attenuated influenza vaccineAttenuated influenza vaccineImmunoglobulin A (IgA) antibodiesLow serum levelsGranulocyte colony-stimulating factorImmunoglobulin G levelsInfluenza virus infectionG-CSF levelsPublic health burdenColony-stimulating factorInterferon response genesMucosal responsesSerum levelsMucosal IgAIP-10Local inflammationAntibody responseTrivalent vaccineA antibodiesHealth burdenLocalized inflammation
2011
Indeterminate QuantiFERON® -TB Gold results in a public health clinic setting
Banach DB, Harris TG. Indeterminate QuantiFERON® -TB Gold results in a public health clinic setting. The International Journal Of Tuberculosis And Lung Disease 2011, 15: 1623-1630. PMID: 22118169, DOI: 10.5588/ijtld.11.0017.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAge FactorsAgedAmbulatory Care FacilitiesChildCross-Sectional StudiesFemaleFollow-Up StudiesHumansInterferon-gamma Release TestsLatent TuberculosisLogistic ModelsMaleMiddle AgedMultivariate AnalysisMycobacterium tuberculosisNew York CityPublic HealthRacial GroupsRetrospective StudiesSex FactorsTuberculosisYoung AdultConceptsIndeterminate resultsIndeterminate QFT-G resultsMultivariate logistic regression analysisQFT-G resultsLogistic regression analysisRace/ethnicityChest clinicPatient characteristicsTB GoldClinic settingQuantiFERONFurther studiesPatientsRegression analysisModest proportionHispanicsNew York CityClinicYork City